30 September – 01 October 2025 | QEII Centre, London, UK
View Official Event Page ›
Join Metabolon at Biomarkers & Precision Medicine 2025
Metabolon is proud to attend the 2025 Biomarkers & Precision Medicine event hosted by Oxford Global. Taking place at the QEII Centre in the heart of London, this conference brings together leaders in biopharma, translational medicine, and diagnostics to explore cutting-edge innovations in biomarker discovery and personalized healthcare.
You will find Kieran Jones, Julian Abril Palacios, Simone de Faria Maraschin, Lisa Storck and Natasa Giallourou in booth #42. Come by to learn more about how metabolomics is redefining biomarker development and unlocking actionable biological insights across the continuum of precision medicine.
Key Themes at Biomarker Discovery and Precision Medicine
Biomarkers & Precision Medicine 2025will explore three key themes:
- Biomarkers: focused on advances in biomarker discovery, validation, clinical utility, and technologies driving precision medicine Multiomic strategies in clinical and translational research.
- Spatial Biology for Precision Medicine: focused on leveraging spatial omics and imaging for translational research and personalized therapies.
- Digital Pathology & AI: focused on computational pathology and AI innovations transforming diagnostic workflows and research.
Metabolomics plays a pivotal role in advancing biomarker discovery and precision medicine by providing a real-time view of the biochemical activities occurring within the body.
The Role of Metabolomics in Biomarker Discovery and Precision Medicine
Unlike genomics or proteomics, which only infer potential function, metabolomics captures the end products of cellular processes, offering real-time insight into physiological states, disease progression, and therapeutic response.
Uniquely, metabolomics sits at the intersection of genetics, lifestyle, the environment and the effect of the microbiome, reflecting the cumulative impact of these factors on an individual’s health. It bridges the gap between genotype and phenotype, accelerating translational research and making precision medicine more predictive, preventive, and effective.
Find out more:
Biomarkers & Precision Medicine Featured Sessions
See full program here
TALK
The Application Of Metabolomics On The AMBROSIA Cohort To Understand ALS
Date: Day 1 – 30 September 2025
Time: 09:40
Location: Conference Room 3: Moore
Speaker: Prof. Dame Pamela Shaw, Professor of Neurology, Director of the Sheffield Institute for Translational Neuroscience (SITraN), Director NIHR Sheffield Biomedical Research Centre, University of Sheffield.
PANEL DISCUSSION
Biomarker Strategies In Neurodegenerative Therapeutics
Date: Day 2 – 01 October 2025
Time: 15:15
Location: Conference Room 1: Westminster
Speaker: Dr. Natasa Giallourou, Field Metabolomics Scientist, Metabolon
Why visiting Metabolon’s booth at Biomarkers & Precision Medicine 2025
With 25 years of scientific expertise, over 4,000 publications, more than 15,000 completed projects, and the world’s largest curated metabolite reference library (with more than 5,400 level 1 and level 2 annotated metabolites), Metabolon is the global leader in metabolomics.
Our platform is built on high-resolution mass spectrometry, rigorous quality controls, and a deep biochemical understanding that ensures accurate identification and quantification of metabolites across diverse sample types.
To maximize the value of metabolomic data, Metabolon offers an Integrated Bioinformatics Platform that empowers researchers to combine other omics datasets (such as genomics, transcriptomics, and proteomics) in a single, unified environment. Designed for collaboration, and with advanced statistical tools, interactive visualizations, machine learning capabilities, the platform enables research teams across disciplines to jointly explore data, annotate findings, and generate hypotheses in real time.
Don’t stay behind – incorporate high-quality metabolomics analysis in your project. Book a meeting with our team using the form on this page,to discover how our biology-first approach reveals novel, clinically actionable biomarkers that drive precision medicine forward.
In the meantime, feel free to browse some helpful resources:
- Metabolomics Solutions for Drug Development Workflows | Metabolon
- Clinical Drug Development | Metabolon
Meet Metabolon’s Team at Biomarkers UK
Kieran Jones, Strategic Account Manager, International.
With a scientific background in immunology and clinical development, he spent several years in pharma and CDMO roles at UCB and Lonza before transitioning into commercial. At Metabolon, he helps biopharma partners integrate metabolomics into their drug development, clinical, and manufacturing programs to accelerate decision-making and biomarker-driven strategy.
Simoné de Faria Maraschin, Director International Sales.
Simoné currently leads the International Sales Team at Metabolon, supporting Metabolon’s customers throughout EMEA and APAC regions. She holds a PhD in Molecular and Cell Biology by Leiden University, The Netherlands. She has worked for more than 15 years for the Agrifood and Lifesciences industry, where she led different research departments. After her MBA in 2016, she has been fully dedicated to providing pre-clinical and clinical research solutions to academic and industrial customers. She is passionate about product innovation and client satisfaction. Simone is based in Tours, France.
Natasa Giallourou, Field Metabolomics Scientist.
Natasa currently supports Metabolon’s International Business activities by providing scientific counsel for metabolomics applications in the biopharma and academic sectors. Natasa obtained her PhD in Metabolomics from the University of Reading. Prior to joining Metabolon, she served as a Marie Skłodowska-Curie Postdoctoral Fellow at biobank.cy. and worked as a Postdoctoral Research Associate at Imperial College London. Natasa has also served for 5 years on the Board of Directors of the International Metabolomics Society.
Lisa Storck, Business Development Executive
As Business Development Executive for South UK, Lisa supports commercial and academic clients advance their research through Metabolon’s world-leading metabolomics solutions. Lisa holds a PhD in Chemical Biology from Imperial College London and brings 12 years of expertise in LC-MS-based analysis of biomolecules. Her passion is combing collaboration and scientific integrity with a consultative approach, to empower clients to translate research into maximum impact. Lisa is based in London.
Connect with us in London to learn how our team can support your biomarker and precision medicine initiatives.
Learn more about the event:
- Official Event Website ›
- Event Dates: 30 September – 01 October 2025
- Location: QEII Centre, London, UK
